ADVANCING CLINICAL COSTING & DRG IMPLEMENTATION IN SAUDI ARABIA WORKSHOP

• Apply advanced, evidence-based strategies for the management of metabolic disorders, including diabetes, obesity, dyslipidemia, and osteoporosis.

• Differentiate between therapeutic options (e.g., GLP-1 receptor agonists, SGLT2 inhibitors, insulin, PCSK9 inhibitors) and select optimal treatments based on patient-specific factors and disease complexity.

• Optimize therapeutic sequencing and de-intensification strategies in complex metabolic conditions using real-world and guideline-based evidence.

• Evaluate emerging therapies and innovations in metabolic disease management, including their clinical outcomes and long-term safety.

• Implement multidisciplinary care models to improve patient outcomes and ensure coordinated management across healthcare teams.

• Translate clinical evidence into practice through case-based discussions and interactive learning.

WORKSHOP OBJECTIVES